CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 18,000 shares at $82.42 ($1,483,560)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Director sold 20,000 shares at $83.68 ($1,673,600)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale President and CEO sold 48,273 shares at an average $84.18 ($4,063,743)
- 4 Open-market sale Chief Financial Officer sold 46,203 shares at an average $83.13 ($3,841,037)
- 4 Open-market sale Chief Medical Officer sold 23,151 shares at an average $82.30 ($1,905,305)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Medical Officer sold 9,514 shares at $82.48 ($784,715)
- 4 Open-market sale President and CEO sold 34,438 shares at $82.48 ($2,840,446)
Page 4 of 36 · 707 filings